Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular Complications

International Journal of Endocrinology

Volumn 2016, Issue , 2016, Pages

  Gómez Hernández, Almudena ^a,b,c   Beneit, Nuria ^a,b,c   Díaz Castroverde, Sabela ^a,b,c   Escribano, Óscar ^a,b,c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; BODY MASS; BROWN ADIPOSE TISSUE; CALORIC RESTRICTION; DISEASE ASSOCIATION; ENERGY BALANCE; ENERGY EXPENDITURE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAPERITONEAL FAT; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PERIVASCULAR ADIPOSE TISSUE; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 84991665915     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2016/1216783     Document Type: Review

References (196)

1. B. Caballero, "The global epidemic of obesity: An overview, " Epidemiologic Reviews, vol. 29, no. 1, pp. 1-5, 2007.
2. G. Cascio, G. Schiera, and I. Di Liegro, "Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases, " Current Diabetes Reviews, vol. 8, no. 1, pp. 2-17, 2012.
3. P. Mathieu, I. Lemieux, and J.-P. Després, "Obesity, inflammation, and cardiovascular risk, " Clinical Pharmacology andTherapeutics, vol. 87, no. 4, pp. 407-416, 2010.
4. W. Aldhahi and O. Hamdy, "Adipokines, inflammation, and the endothelium in diabetes, " Current Diabetes Reports, vol. 3, no. 4, pp. 293-298, 2003.
5. B. B. Lowell, V. S-Susulic, A. Hamann et al., "Development of obesity in transgenic mice after genetic ablation of brown adipose tissue, " Nature, vol. 366, no. 6457, pp. 740-742, 1993.
6. X. Yang, S. Enerbäck, and U. Smith, "Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance, "Obesity Research, vol. 11, no. 10, pp. 1182-1191, 2003.
7. K. Almind, M. Manieri, W. I. Sivitz, S. Cinti, and C. R. Kahn, "Ectopic brown adipose tissue inmuscle provides a mechanism for differences in risk of metabolic syndrome in mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2366-2371, 2007.
8. M. P. Mattson, "Perspective: does brown fat protect against diseases of aging" Ageing Research Reviews, vol. 9, no. 1, pp. 69-76, 2010.
9. M. T. Foster and T. J. Bartness, "Sympathetic but not sensory denervation stimulates white adipocyte proliferation, " American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 291, no. 6, pp. R1630-R1637, 2006.
10. F. Kreier, E. Fliers, P. J. Voshol et al., "Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications, " Journal of Clinical Investigation, vol. 110, no. 9, pp. 1243-1250, 2002.
11. A. Giordano, C. K. Song, R. R. Bowers et al., "No sympathy for the claim of parasympathetic innervation of white adipose tissue, " American Journal of Physiology, vol. 293, pp. R550-R552, 2007.
12. H. R. Berthoud, E. A. Fox, andW. L. Neuhuber, "Controversial white adipose tissue innervation by the vagus nerve: seeing is believing, " American Journal of Physiology, vol. 293, pp. R553-R554, 2007.
13. T. J. Bartness, Y. Liu, Y. B. Shrestha, and V. Ryu, "Neural innervation of white adipose tissue and the control of lipolysis, " Frontiers in Neuroendocrinology, vol. 35, no. 4, pp. 473-493, 2014.
14. P. R. Johnson, L. M. Zucker, J. A. Cruce, and J. Hirsch, "Cellularity of adipose depots in the genetically obese Zucker rat, " Journal of Lipid Research, vol. 12, no. 6, pp. 706-714, 1971.
15. M. Krotkiewski, P. Björntorp, L. Sjöström, and U. Smith, "Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution, " Journal of Clinical Investigation, vol. 72, no. 3, pp. 1150-1162, 1983.
16. P. J. Coon, E. M. Rogus, D. Drinkwater, D. C. Muller, and A. P. Goldberg, "Role of body fat distribution in the decline ininsulin sensitivity and glucose tolerance with age, " Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 4, pp. 1125-1132, 1992.
17. A. Gastaldelli, Y. Miyazaki, M. Pettiti et al., "Metabolic effects of visceral fat accumulation in type 2 diabetes, " Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 5098-5103, 2002.
18. P. Marin, B. Andersson, M. Ottosson et al., "The morphology and metabolism of intraabdominal adipose tissue in men, " Metabolism, vol. 41, no. 11, pp. 1242-1248, 1992.
19. C. T. Montague, J. B. Prins, L. Sanders, J. E. Digby, and S. O'Rahilly, "Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution, " Diabetes, vol. 46, no. 3, pp. 342-347, 1997.
20. B. L. Wajchenberg, "Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome, " Endocrine Reviews, vol. 21, no. 6, pp. 697-738, 2000.
21. P. Björntorp, "Metabolic implications of body fat distribution, " Diabetes Care, vol. 14, no. 12, pp. 1132-1143, 1991.
22. M. Gaggini, C. Saponaro, and A. Gastaldelli, "Not all fats are created equal: Adipose vs. ectopic fat, implication in cardiometabolic diseases, "HormoneMolecular Biology and Clinical Investigation, vol. 22, no. 1, pp. 7-18, 2015.
23. J. Hellmér, C. Marcus, T. Sonnenfeld, and P. Arner, "Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells, " Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 1, pp. 15-20, 1992.
24. J. Himms-Hagen, "Neural control of brown adipose tissue thermogenesis, hypertrophy, and atrophy, " Frontiers in Neuroendocrinology, vol. 12, no. 1, pp. 38-93, 1991.
25. T. J. Bartness, C. K. Song, and G. E. Demas, "Central nervous system innervation of brown adipose tissue, " in Adipose Tissue, S. Klaus, Ed., pp. 162-200, Landes Bioscience, Georgetown, Tex, USA, 2001.
26. T. J. Bartness and C. K. Song, "Innervation of brown adipose tissue and its role in thermogenesis, " Canadian Journal of Diabetes, vol. 29, no. 4, pp. 420-428, 2005.
27. A. Giordano, A. Frontini, M. Castellucci, andS. Cinti, "Presence and distribution of cholinergic nerves in rat mediastinal brown adipose tissue, " Journal of Histochemistry and Cytochemistry, vol. 52, no. 7, pp. 923-930, 2004.
28. M. K.-H. Schäfer, L. E. Eiden, and E. Weihe, "Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. II. The peripheral nervous system, " Neuroscience, vol. 84, no. 2, pp. 361-376, 1998.
29. D. Norman, S. Mukherjee, D. Symons, R. T. Jung, and J. D. Lever, "Neuropeptides in interscapular and perirenal brown adipose tissue in the rat: A plurality of innervation, " Journal of Neurocytology, vol. 17, no. 3, pp. 305-311, 1988.
30. A. Giordano, M. Morroni, G. Santone, G. F. Marchesi, and S. Cinti, "Tyrosine hydroxylase, neuropeptide Y, substance P, calcitonin gene-related peptide and vasoactive intestinal peptide in nerves of rat periovarian adipose tissue: An immunohistochemical and ultrastructural investigation, " Journal of Neurocytology, vol. 25, no. 2, pp. 125-136, 1996.
31. J. D. Lever, S. Mukherjee, D. Norman, D. Symons, and R. T. Jung, "Neuropeptide and noradrenaline distributions in rat interscapular brown fat and in its intact and obstructed nerves of supply, " Journal of the Autonomic Nervous System, vol. 25, no. 1, pp. 15-25, 1988.
32. A. M. Cypess, S. Lehman, G. Williams et al., "Identification and importance of brown adipose tissue in adult humans, " The New England Journal ofMedicine, vol. 360, no. 15, pp. 1509-1517, 2009.
33. J. Lshibashi and P. Seale, "Beige can be slimming, " Science, vol. 328, no. 5982, pp. 1113-1114, 2010.
34. M. Cedikova, M. Kripnerová, J. Dvorakova et al., "Mitochondria in white, brown, and beige adipocytes, " Stem Cells International, vol. 2016, Article ID 6067349, 11 pages, 2016.
35. M. Giralt and F. Villarroya, "White, brown, beige/brite: different adipose cells for different functions" Endocrinology, vol. 154, no. 9, pp. 2992-3000, 2013.
36. J. Wu, P. Boström, L. M. Sparks et al., "Beige adipocytes are a distinct type of thermogenic fat cell inmouse and human, " Cell, vol. 150, no. 2, pp. 366-376, 2012.
37. P. Boström, J. Wu, M. P. Jedrychowski et al., "A PGC1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, " Nature, vol. 481, no. 7382, pp. 463-468, 2012.
38. T.-Y. Liu, C.-X. Shi, R. Gao et al., "Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes, " Clinical Science, vol. 129, no. 10, pp. 839-850, 2015.
39. J. Lu, G. Xiang, M. Liu, W. Mei, L. Xiang, and J. Dong, "Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice, " Atherosclerosis, vol. 243, no. 2, pp. 438-448, 2015.
40. F. Han, S. Zhang, N. Hou, D. Wang, and X. Sun, "Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 309, no. 9, pp. H1501-H1508, 2016.
41. A. Bartelt, O. T. Bruns, R. Reimer et al., "Brown adipose tissue activity controls triglyceride clearance, " Nature Medicine, vol. 17, no. 2, pp. 200-205, 2011.
42. G. Hoeke, S. Kooijman, M. R. Boon, P. C. N. Rensen, and J. F. P. Berbeé, "Role of brown fat in lipoprotein metabolism and atherosclerosis, " Circulation Research, vol. 118, no. 1, pp. 173-182, 2016.
43. D. Medrikova, T. P. Sijmonsma, K. Sowodniok et al., "Brown adipose tissue harbors a distinct sub-population of regulatory T cells, " PLoS ONE, vol. 10, no. 2, article e0118534, 2015.
44. R. I. Meijer, E. H. Serne, Y. M. Smulders, V. W. M. van Hinsbergh, J. S. Yudkin, and E. C. Eringa, "Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease, " Current Diabetes Reports, vol. 11, no. 3, pp. 211-217, 2011.
45. B. Cannon and J. Nedergaard, "Brown adipose tissue: function and physiological significance, " Physiological Reviews, vol. 84, no. 1, pp. 277-359, 2004.
46. S. B. Police, S. E. Thatcher, R. Charnigo, A. Daugherty, and L. A. Cassis, "Obesity promotes inflammation in periaortic adipose tissue and angiotensin ii-induced abdominal aortic aneurysm formation, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 10, pp. 1458-1464, 2009.
47. L. Chang, L. Villacorta, R. Li et al., "Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis, " Circulation, vol. 126, no. 9, pp. 1067-1078, 2012.
48. M. R. Dashwood and A. Loesch, "Does perivascular fat influence neural control of thesaphenous vein, " Current Neurobiology Journal, vol. 2, pp. 71-74, 2011.
49. G. Frühbeck, J. Gómez-Ambrosi, F. J. Muruzábal, and M. A. Burrell, "The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation, " American Journal of Physiology-Endocrinology and Metabolism, vol. 280, no. 6, pp. E827-E847, 2001.
50. A. Mart, B. Berraondo, and J. A. Martnez, "Leptin: physiological actions, " Journal of Physiology and Biochemistry, vol. 55, no. 1, pp. 43-49, 1999.
51. M. Nakata, T. Yada, N. Soejima, and I. Maruyama, "Leptin promotes aggregation of human platelets via the long form of its receptor, " Diabetes, vol. 48, no. 2, pp. 426-429, 1999.
52. J. B. McGill, D. J. Schneider, C. L. Arfken, C. L. Lucore, and B. E. Sobel, "Factors responsible for impaired fibrinolysis in obese subjects and NIDDMpatients, " Diabetes, vol. 43, no. 1, pp. 104-109, 1994.
53. Y. Arita, S. Kihara, N. Ouchi et al., "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, " Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79-83, 1999.
54. K. Hotta, T. Funahashi, Y. Arita et al., "Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 6, pp. 1595-1599, 2000.
55. T. Pischon, C. J. Girman, G. S. Hotamisligil, N. Rifai, F. B. Hu, and E. B. Rimm, "Plasma adiponectin levels and risk of myocardial infarction in men, " Journal of the American Medical Association, vol. 291, no. 14, pp. 1730-1737, 2004.
56. N. Ouchi, S. Kihara, Y. Arita et al., "Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, " Circulation, vol. 103, no. 8, pp. 1057-1063, 2001.
57. M. Ryo, T. Nakamura, S. Kihara et al., "Adiponectin as a biomarker of the metabolic syndrome, " Circulation Journal, vol. 68, no. 11, pp. 975-981, 2004.
58. M. Kumada, S. Kihara, S. Sumitsuji et al., "Association of hypoadiponectinemia with coronary artery disease in men, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 1, pp. 85-89, 2003.
59. G. Pandey, M. S. Shihabudeen, H. P. David, E. Thirumurugan, and K. Thirumurugan, "Association between hyperleptinemia and oxidative stress in obese diabetic subjects, " Journal of Diabetes & Metabolic Disorders, vol. 14, no. 1, article 24, 2015.
60. G. Winkler, S. Kiss, L. Keszthelyi et al., "Expression of tumor necrosis factor (TNF)-protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-, soluble serum TNF-receptor-2 concentrations and C-peptide level, " European Journal of Endocrinology, vol. 149, no. 2, pp. 129-135, 2003.
61. G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman, "Increased adipose tissue expression of tumor necrosis factor-in human obesity and insulin resistance, " Journal of Clinical Investigation, vol. 95, no. 5, pp. 2409-2415, 1995.
62. G. S. Hotamisligil, "Inflammation and metabolic disorders, " Nature, vol. 444, no. 7121, pp. 860-867, 2006.
63. G. S. Hotamisligil, A. Budavari, D. Murray, and B. M. Spiegelman, "Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha, " The Journal of Clinical Investigation, vol. 94, no. 4, pp. 1543-1549, 1994.
64. M. Takano, R. Nishihara, N. Sugano et al., "The effect of systemic anti-tumor necrosis factor-alpha treatment on Porphyromonas gingivalis infection in type 2 diabetic mice, " Archives of Oral Biology, vol. 55, no. 5, pp. 379-384, 2010.
65. B. Yazdani-Biuki, H. Stelzl, H. P. Brezinschek et al., "Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-antibody infliximab, " European Journal of Clinical Investigation, vol. 34, no. 9, pp. 641-642, 2004.
66. A. Gómez-Hernández, Y. F. Otero, N. De Las Heras et al., "Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction, " Endocrinology, vol. 153, no. 3, pp. 1242-1255, 2012.
67. V. Van Harmelen, P. Ariapart, J. Hoffstedt, I. Lundkvist, S. Bringman, and P. Arner, "Increased adipose angiotensinogen gene expression in human obesity, " Obesity Research, vol. 8, no. 4, pp. 337-341, 2000.
68. I. Shimomura, T. Funahashi, M. Takahashi et al., "Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity, " Nature Medicine, vol. 2, no. 7, pp. 800-803, 1996.
69. B. H. Jones, M. K. Standridge, and N. Moustaid, "Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells, " Endocrinology, vol. 138, no. 4, pp. 1512-1519, 1997.
70. D. V. Chartoumpekis, I. G. Habeos, P. G. Ziros, A. I. Psyrogiannis, V. E. Kyriazopoulou, and A. G. Papavassiliou, "Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21, " Molecular Medicine, vol. 17, no. 7-8, pp. 736-740, 2011.
71. E. Hondares, M. Rosell, F. J. Gonzalez, M. Giralt, R. Iglesias, and F. Villarroya, "Hepatic FGF21 expression is induced at birth via PPAR in response to milk intake and contributes to thermogenic activation of neonatal brown fat, " CellMetabolism, vol. 11, no. 3, pp. 206-212, 2010.
72. J. Villarroya, R. Cereijo, and F. Villarroya, "An endocrine role for brown adipose tissue" American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 5, pp. E567-E572, 2013.
73. E. Hondares, R. Iglesias, A. Giralt et al., "Thermogenic activation induces FGF21 expression and release in brown adipose tissue, " Journal of Biological Chemistry, vol. 286, no. 15, pp. 12983-12990, 2011.
74. E. Nisoli, C. Tonello, andM. O. Carruba, "Nerve growth factor, 3-adrenoceptor and uncoupling protein 1 expression in rat brown fat during postnatal development, " Neuroscience Letters, vol. 246, no. 1, pp. 5-8, 1998.
75. F. Sornelli, M. Fiore, G. N. Chaldakov, and L. Aloe, "Adipose tissue-derived nerve growth factor and brain-derived neurotrophic factor: results fromexperimental stress and diabetes, " General Physiology and Biophysics, vol. 28, pp. 179-183, 2009.
76. C. Tonello, A. Giordano, V. Cozzi et al., "Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats, " FEBS Letters, vol. 442, no. 2-3, pp. 167-172, 1999.
77. K. Kikuchi-Utsumi, B. Gao, H. Ohinata, M. Hashimoto, N. Yamamoto, and A. Kuroshima, "Enhanced gene expression of endothelial nitric oxide synthase in brown adipose tissue during cold exposure, " American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 282, no. 2, pp. R623-R626, 2002.
78. T. P. Fitzgibbons, S. Kogan, M. Aouadi, G. M. Hendricks, J. Straubhaar, and M. P. Czech, "Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 301, no. 4, pp. H1425-H1437, 2011.
79. M. T. Ortega, L. Xie, S. Mora, and S. K. Chapes, "Evaluation of macrophage plasticity in brown and white adipose tissue, " Cellular Immunology, vol. 271, no. 1, pp. 124-133, 2011.
80. L. Chang, H. Milton, D. T. Eitzman, and Y. E. Chen, "Paradoxical roles of perivascular adipose tissue in atherosclerosis and hypertension, " Circulation Journal, vol. 77, no. 1, pp. 11-18, 2013.
81. M. Takaoka, H. Suzuki, S. Shioda et al., "Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1576-1582, 2010.
82. T. K. Chatterjee, L. L. Stoll, G. M. Denning et al., "Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding, " Circulation Research, vol. 104, no. 4, pp. 541-549, 2009.
83. K. Rittig, J. H. Dolderer, B. Balletshofer et al., "The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells, " Diabetologia, vol. 55, no. 5, pp. 1514-1525, 2012.
84. J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth, "Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans, " Endocrinology, vol. 145, no. 5, pp. 2273-2282, 2004.
85. M. B. Snijder, J. M. Dekker, M. Visser et al., "Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: The Hoorn study, " The American Journal of Clinical Nutrition, vol. 77, no. 5, pp. 1192-1197, 2003.
86. C. S. Fox, J. M. Massaro, U. Hoffmann et al., "Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study, " Circulation, vol. 116, no. 1, pp. 39-48, 2007.
87. A. Gil, C. M. Aguilera, M. Gil-Campos, and R. Cañete, "Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity, " British Journal of Nutrition, vol. 98, no. 1, pp. S121-S126, 2007.
88. R. G. Baker, M. S. Hayden, and S. Ghosh, "NF-B, inflammation, and metabolic disease, " Cell Metabolism, vol. 13, no. 1, pp. 11-22, 2011.
89. A. Chawla, K. D. Nguyen, and Y. P. S. Goh, "Macrophagemediated inflammation in metabolic disease, " Nature Reviews Immunology, vol. 11, no. 11, pp. 738-749, 2011.
90. S. Nishimura, I. Manabe, M. Nagasaki et al., "CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity, " Nature Medicine, vol. 15, no. 8, pp. 914-920, 2009.
91. D. L. Crandall, G. J. Hausman, and J. G. Kral, "A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives, "Microcirculation, vol. 4, no. 2, pp. 211-232, 1997.
92. G. J. Blake and P. M. Ridker, "Inflammatory bio-markers and cardiovascular risk prediction, " Journal of InternalMedicine, vol. 252, no. 4, pp. 283-294, 2002.
93. C. Sengenès, A. Miranville, K. Lolmède, C. A. Curat, and A. Bouloumíe, "The role of endothelial cells in inflamed adipose tissue, " Journal of InternalMedicine, vol. 262, no. 4, pp. 415-421, 2007.
94. D. Cai, M. Yuan, D. F. Frantz et al., "Local and systemic insulin resistance resulting from hepatic activation of IKK-and NF-B, " Nature Medicine, vol. 11, no. 2, pp. 183-190, 2005.
95. V. Racanelli and B. Rehermann, "The liver as an immunological organ, " Hepatology, vol. 43, no. 2, supplement, pp. S54-S62, 2006.
96. S. E. Shoelson, J. Lee, and A. B. Goldfine, "Inflammation and insulin resistance, " Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793-1801, 2006.
97. X. Terra, T. Auguet, I. Quesada et al., "Increased levels and adipose tissue expression of visfatin in morbidly obese women: The relationship with pro-inflammatory cytokines, " Clinical Endocrinology, vol. 77, no. 5, pp. 691-698, 2012.
98. F. Gunes, E. Akbal, E. Cakir, O. Akyurek, M. Altunbas, and M. Ozbek, "Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients, " Internal Medicine, vol. 51, no. 6, pp. 553-557, 2012.
99. T. Romacho, C. F. Sánchez-Ferrer, and C. Peiró, "Visfatin/ Nampt: An adipokine with cardiovascular impact, " Mediators of Inflammation, vol. 2013, Article ID 946427, 15 pages, 2013.
100. Y.-N. Chae, T.-H. Kim, M.-K. Kim et al., "Beneficial effects of evogliptin, a novel dipeptidyl peptidase 4 inhibitor, on adiposity with increased Ppargc1a in white adipose tissue in obese mice, " PLoS ONE, vol. 10, no. 12, Article ID e0144064, 2015.
101. K. Blaslov, T. Bulum, and L. Duvnjak, "Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients, " Journal of Diabetes and Its Complications, vol. 29, no. 3, pp. 390-394, 2015.
102. H. Sell, M. Blüher, N. Klöting et al., "Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro, " Diabetes Care, vol. 36, no. 12, pp. 4083-4090, 2013.
103. W. S. D. Silva J?unior, A. F. D. Godoy-Matos, and L. G. Kraemer-Aguiar, "Dipeptidyl peptidase 4: A new link between diabetes mellitus and atherosclerosis" BioMed Research International, vol. 2015, Article ID816164, 10 pages, 2015.
104. M. Ghorbani, T. H. Claus, and J. Himms-Hagen, "Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a 3-adrenoceptor agonist, " Biochemical Pharmacology, vol. 54, no. 1, pp. 121-131, 1997.
105. C. Guerra, P. Navarro, A. M. Valverde et al., "Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance, " The Journal of Clinical Investigation, vol. 108, no. 8, pp. 1205-1213, 2001.
106. Y. Kontani, Y. Wang, K. Kimura et al., "UCP1 deficiency increases susceptibility to diet-induced obesity with age, " Aging Cell, vol. 4, no. 3, pp. 147-155, 2005.
107. J. B. Hansen and K. Kristiansen, "Regulatory circuits controlling white versus brown adipocyte differentiation, " Biochemical Journal, vol. 398, no. 2, pp. 153-168, 2006.
108. A. Bartelt, M. Merkel, and J. Heeren, "A new, powerful player in lipoprotein metabolism: brown adipose tissue, " Journal of Molecular Medicine, vol. 90, no. 8, pp. 887-893, 2012.
109. K. J. Williams, "Molecular processes that handle-and mishandle-dietary lipids, "The Journal of Clinical Investigation, vol. 118, no. 10, pp. 3247-3259, 2008.
110. J. E. Hokanson and M. A. Austin, "Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies, " Journal of Cardiovascular Risk, vol. 3, no. 2, pp. 213-219, 1996.
111. A. D. Mooradian, "Dyslipidemia in type 2 diabetes mellitus, " Nature Clinical Practice Endocrinology &Metabolism, vol. 5, no. 3, pp. 150-159, 2009.
112. J. M. Fredriksson, H. Nikami, and J. Nedergaard, "Coldinduced expression of the VEGF gene in brown adipose tissue is independent of thermogenic oxygen consumption, " FEBS Letters, vol. 579, no. 25, pp. 5680-5684, 2005.
113. J. R. D. Mitchell, A. Jacobsson, T. G. Kirchgessner, M. C. Schotz, B. Cannon, and J. Nedergaard, "Regulation of expression of the lipoprotein lipase gene in brown adipose tissue, " American Journal of Physiology-Endocrinology and Metabolism, vol. 263, no. 3, part 1, pp. E500-E506, 1992.
114. V. Ouellet, S. M. Labbé, D. P. Blondin et al., "Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans, "The Journal of Clinical Investigation, vol. 122, no. 2, pp. 545-552, 2012.
115. I. G. Shabalina, A. Jacobsson, B. Cannon, and J. Nedergaard, "Native UCP1 displays simple competitive kinetics between the regulators purine nucleotides and fatty acids, " The Journal of Biological Chemistry, vol. 279, no. 37, pp. 38236-38248, 2004.
116. O. S. Dallner, E. Chernogubova, K. A. Brolinson, and T. Bengtsson, "3-adrenergic receptors stimulate glucose uptake in brown adipocytes by two mechanisms independently of glucose transporter 4 translocation, " Endocrinology, vol. 147, no. 12, pp. 5730-5739, 2006.
117. H. Nikami, Y. Shimizu, D. Endoh, H. Yano, and M. Saito, "Cold exposure increases glucose utilization and glucose transporter expression in brown adipose tissue, " Biochemical and Biophysical Research Communications, vol. 185, no. 3, pp. 1078-1082, 1992.
118. Q. Hao, R. Yadav, A. L. Basse et al., "Transcriptome profiling of brown adipose tissue during cold exposure reveals extensive regulation of glucose metabolism, " American Journal of Physiology-Endocrinology and Metabolism, vol. 308, no. 5, pp. E380-E392, 2015.
119. G. Ozen, A. Daci, X. Norel, and G. Topal, "Human perivascular adipose tissue dysfunction as a cause of vascular disease: focus on vascular tone and wall remodeling, " European Journal of Pharmacology, vol. 766, pp. 16-24, 2015.
120. N. K. Brown, Z. Zhou, J. Zhang et al., "Perivascular adipose tissue in vascular function and disease: A review of current research and animal models, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 8, pp. 1621-1630, 2014.
121. A. Omar, T. K. Chatterjee, Y. Tang, D. Y. Hui, and N. L. Weintraub, "Proinflammatory phenotype of perivascular adipocytes, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 8, pp. 1631-1636, 2014.
122. C. E. Bussey, S. B. Withers, R. G. Aldous, G. Edwards, andA. M. Heagerty, "Obesity-related perivascular adipose tissue damage is reversed by sustained weight loss in the rat, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 7, pp. 1377-1385, 2016.
123. A. S. Greenstein, K. Khavandi, S. B. Withers et al., "Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients, " Circulation, vol. 119, no. 12, pp. 1661-1670, 2009.
124. R. Aghamohammadzadeh, R. D. Unwin, A. S. Greenstein, and A. M. Heagerty, "Effects of obesity on perivascular adipose tissue vasorelaxant function: nitric oxide, inflammation and elevated systemic blood pressure, " Journal of Vascular Research, vol. 52, no. 5, pp. 299-305, 2016.
125. E. C. Eringa, W. Bakker, andV. W. M. vanHinsbergh, "Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue, " Vascular Pharmacology, vol. 56, no. 5-6, pp. 204-209, 2012.
126. K. Rittig, K. Staib, J. Machann et al., "Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction, " Diabetologia, vol. 51, no. 11, pp. 2093-2099, 2008.
127. S. E. Feldon, C. W. O'Loughlin, D. M. Ray, S. Landskroner-Eiger, K. E. Seweryniak, and R. P. Phipps, "Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes, " The American Journal of Pathology, vol. 169, no. 4, pp. 1183-1193, 2006.
128. G. A. Payne, L. Borbouse, S. Kumar et al., "Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-pathway, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1711-1717, 2010.
129. E. Henrichot, C. E. Juge-Aubry, A. Pernin et al., "Production of chemokines by perivascular adipose tissue: A role in the pathogenesis of atherosclerosis" Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2594-2599, 2005.
130. C. Marchesi, T. Ebrahimian, O. Angulo, P. Paradis, and E. L. Schiffrin, "Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome, " Hypertension, vol. 54, no. 6, pp. 1384-1392, 2009.
131. H. S. Sacks and J. N. Fain, "Human epicardial fat: what is new and what is missing" Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 12, pp. 879-887, 2011.
132. T. Mazurek, L. Zhang, A. Zalewski et al., "Human epicardial adipose tissue is a source of inflammatory mediators, " Circulation, vol. 108, no. 20, pp. 2460-2466, 2003.
133. L. M. Redman and E. Ravussin, "Endocrine alterations in response to calorie restriction in humans, " Molecular and Cellular Endocrinology, vol. 299, no. 1, pp. 129-136, 2009.
134. A. Howell, M. Chapman, and M. Harvie, "Energy restriction for breast cancer prevention, " Recent Results in Cancer Research, vol. 181, pp. 97-111, 2009.
135. G. López-Lluch, N. Hunt, B. Jones et al., "Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 6, pp. 1768-1773, 2006.
136. J. C. Seidell, "Environmental influences on regional fat distribution, " International Journal of Obesity, vol. 15, supplement 2, pp. 31-35, 1991.
137. K. A. Varady, S. Bhutani, M. C. Klempel, and C. M. Kroeger, "Comparison of effects of diet versus exercise weight loss regimens on LDL andHDL particle size in obese adults, " Lipids in Health and Disease, vol. 10, article 119, 2011.
138. W. H. M. Saris, "Effects of energy restriction and exercise on the sympathetic nervous system, " International Journal of Obesity, vol. 19, no. 7, pp. S17-S23, 1995.
139. E. Zorba, T. Cengiz, and K. Karacabey, "Exercise training improves body composition, blood lipid profile and serum insulin levels in obese children, " Journal of Sports Medicine and Physical Fitness, vol. 51, no. 4, pp. 664-669, 2011.
140. B. Lamarche, J.-P. Despres, S. Moorjani et al., "Evidence for a role of insulin in the regulation of abdominal adipose tissue lipoprotein lipase response to exercise training in obesewomen, " International Journal of Obesity, vol. 17, no. 5, pp. 255-261, 1993.
141. A. Tremblay, A. Nadeau, J.-P. Després, L. St-Jean, G. Thériault, and C. Bouchard, "Long-term exercise training with constant energy intake. 2: effect on glucose metabolism and resting energy expenditure, " International Journal ofObesity, vol. 14, no. 1, pp. 75-84, 1990.
142. D. Richard, "Cognitive and autonomic determinants of energy homeostasis in obesity, " Nature Reviews Endocrinology, vol. 11, no. 8, pp. 489-501, 2015.
143. S. C. Woods, "The control of food intake: behavioral versus molecular perspectives, " CellMetabolism, vol. 9, no. 6, pp. 489-498, 2009.
144. J. M. Friedman and J. L. Halaas, "Leptin and the regulation of body weight in mammals, " Nature, vol. 395, no. 6704, pp. 763-770, 1998.
145. H. Münzberg and C. D. Morrison, "Structure, production and signaling of leptin, "Metabolism: Clinical and Experimental, vol. 64, no. 1, pp. 13-23, 2015.
146. Z. Jovanovic and G. S. H. Yeo, "Central leptin signalling: beyond the arcuate nucleus, "AutonomicNeuroscience: Basic and Clinical, vol. 156, no. 1-2, pp. 8-14, 2010.
147. M. Perello and S. L. Dickson, "Ghrelin signalling on food reward: A salient link between the gut and the mesolimbic system, " Journal of Neuroendocrinology, vol. 27, no. 6, pp. 424-434, 2015.
148. H. Kirchner, K. M. Heppner, and M. H. Tschöp, "The role of ghrelin in the control of energy balance, " Handbook of Experimental Pharmacology, vol. 209, pp. 161-184, 2012.
149. P. Behary and A. D. Miras, "Brain responses to food and weight loss, " Experimental Physiology, vol. 99, no. 9, pp. 1121-1127, 2014.
150. P. Sumithran, L. A. Prendergast, E. Delbridge et al., "Long-term persistence of hormonal adaptations to weight loss, " The New England Journal ofMedicine, vol. 365, no. 17, pp. 1597-1604, 2011.
151. M. Rosenbaum and R. L. Leibel, "Adaptive thermogenesis in humans, " International Journal of Obesity, vol. 34, no. 1, pp. S47-S55, 2010.
152. A. Tremblay, M.-M. Royer, J.-P. Chaput, and é. Doucet, "Adaptive thermogenesis can make a difference in the ability of obese individuals to lose body weight, " International Journal of Obesity, vol. 37, no. 6, pp. 759-764, 2013.
153. S. Z. Yanovski and J. A. Yanovski, "Long-term drug treatment for obesity: A systematic and clinical review, "The Journal of the American Medical Association, vol. 311, no. 1, pp. 74-86, 2014.
154. Eisai Inc, "BELVIQ (lorcaserin hydrochloride) tablets, for oral use, " Patient Package Insert, 2013, http://www. Accessdata. fda. gov/drugsatfda docs/label/2012/022529lbl. pdf.
155. Vivus Inc, "Qsymia (phentermine and topiramate extended-release) capsules, for oral use, " Patient package, 2013, http://www. Accessdata. fda. gov/drugsatfda docs/label/2013/022580s004lbl. pdf.
156. G. Derosa and P. Maffioli, "Anti-obesity drugs: A review about their effects and their safety, " Expert Opinion on Drug Safety, vol. 11, no. 3, pp. 459-471, 2012.
157. A. Khan, S. Raza, Y. Khan et al., "Current updates in the medical management of obesity, " Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, vol. 6, no. 2, pp. 117-128, 2012.
158. P. M. O'Neil, S. R. Smith, N. J. Weissman et al., "Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: The BLOOM-DM study, " Obesity, vol. 20, no. 7, pp. 1426-1436, 2012.
159. K. H. Saunders, R. B. Kumar, L. I. Igel, and L. J. Aronne, "Pharmacologic approaches to weight management: recent gains and shortfalls in combating obesity, " CurrentAtherosclerosis Reports, vol. 18, no. 7, 2016.
160. A. Cahn and I. Raz, "Emerging gliptins for type 2 diabetes, " Expert Opinion on Emerging Drugs, vol. 18, no. 2, pp. 245-258, 2013.
161. J. P. Lomenick, M. S. Buchowski, and A. H. Shoemaker, "A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity, " Obesity, vol. 24, no. 6, pp. 1222-1225, 2016.
162. J. Y. Hong, K. Y. Park, B. J. Kim, W. M. Hwang, D. Kim, and D. Lim, "Effects of short-term exenatide treatment on regional fat distribution, glycated hemoglobin levels, and aortic pulse wave velocity of obese type 2 diabetes mellitus patients, " Endocrinology and Metabolism, vol. 31, no. 1, pp. 80-85, 2016.
163. F. Sun, S. Chai, L. Li et al., "Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: A systematic review and network meta-analysis, " Journal of Diabetes Research, vol. 2015, Article ID 157201, 9 pages, 2015.
164. A. L. P. Harmel, D. M. Kendall, J. B. Buse, P. J. Boyle, A. Marchetti, and H. Lau, "Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes, " Current Medical Research and Opinion, vol. 20, no. 2, pp. 215-223, 2004.
165. J. Hetzel, B. Balletshofer, K. Rittig et al., "Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 9, pp. 1804-1809, 2005.
166. V. Pasceri, H. D. Wu, J. T. Willerson, and E. T. H. Yeh, "Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-activators, " Circulation, vol. 101, no. 3, pp. 235-238, 2000.
167. A. Rubenstrunk, R. Hanf, D. W. Hum, J.-C. Fruchart, and B. Staels, "Safety issues and prospects for future generations of PPAR modulators, " Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1771, no. 8, pp. 1065-1081, 2007.
168. L. Villacorta, F. J. Schopfer, J. Zhang, B. A. Freeman, and Y. E. Chen, "PPAR and its ligands: Therapeutic implications in cardiovascular disease, " Clinical Science, vol. 116, no. 3, pp. 205-218, 2009.
169. J. C. Silva, F. A. César, E. M. de Oliveira et al., "NewPPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr/ mice, " Pharmacological Research, vol. 104, pp. 49-60, 2016.
170. M. YenandM. B. Ewald, "Toxicityofweight loss agents, " Journal of Medical Toxicology, vol. 8, no. 2, pp. 145-152, 2012.
171. D. Langin, "Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome, " Pharmacological Research, vol. 53, no. 6, pp. 482-491, 2006.
172. S. Enerbäck, "Human brown adipose tissue, " Cell Metabolism, vol. 11, no. 4, pp. 248-252, 2010.
173. D. Langin, "Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity" Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1801, no. 3, pp. 372-376, 2010.
174. A.-L. Poher, J. Altirriba, C. Veyrat-Durebex, and F. Rohner-Jeanrenaud, "Brown adipose tissue activity as a target for thetreatment of obesity/insulin resistance, " Frontiers in Physiology, vol. 6, article 4, 2015.
175. S. R. Farmer, "Brown fat and skeletalmuscle: unlikely cousins" Cell, vol. 134, no. 5, pp. 726-727, 2008.
176. T. J. Schulz, T. L. Huang, T. T. Tran et al., "Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 143-148, 2011.
177. C. Weyer, P. A. Tataranni, S. Snitker, E. Danforth Jr., and E. Ravussin, "Increase in insulin action and fat oxidation after treatment with CL 316, 243, a highly selective 3-adrenoceptor agonist in humans, " Diabetes, vol. 47, no. 10, pp. 1555-1561, 1998.
178. T. M. Larsen, S. Toubro, M. A. Van Baak et al., "Effect of a 28-d treatment with L-796568, a novel 3-adrenergic receptor agonist, on energy expenditure and body composition in obese men, " American Journal of Clinical Nutrition, vol. 76, no. 4, pp. 780-788, 2002.
179. L. M. Redman, L. De Jonge, X. Fang et al., "Lack of an effect of a novel 3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: A double-blind, Placebo-Controlled Randomized Study, " Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 527-531, 2007.
180. A. M. Cypess, L. S. Weiner, C. Roberts-Toler et al., "Activation of human brown adipose tissue by a 3-adrenergic receptor agonist, " Cell Metabolism, vol. 21, no. 1, pp. 33-38, 2015.
181. K. L. Townsend and Y. H. Tseng, "Brown adipose tissue. Recent insights into development, metabolic function and therapeutic potential, " Adipocyte, vol. 1, no. 1, pp. 13-24, 2012.
182. A. Rodrguez, S. Becerril, S. Ezquerro, L. Méndez-Giménez, and G. Frühbeck, "Cross-talk between adipokines and myokines in fat browning, " Acta Physiologica, 2016.
183. D. M. Sepa-Kishi and R. B. Ceddia, "Exercise-mediated effects on white and brown adipose tissue plasticity and metabolism, " Exercise and Sport Sciences Reviews, vol. 44, no. 1, pp. 37-44, 2016.
184. T. L. Rachid, A. Penna-de-Carvalho, I. Bringhenti, M. B. Aguila, C. A. Mandarim-de-Lacerda, and V. Souza-Mello, "Fenofibrate (PPAR agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice, " Molecular and Cellular Endocrinology, vol. 40, pp. 86-94, 2015.
185. N. Petrovic, T. B. Walden, I. G. Shabalina, J. A. Timmons, B. Cannon, and J. Nedergaard, "Chronic peroxisome proliferatoractivated receptor (PPAR) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct fromclassic brown adipocytes, "TheJournal of Biological Chemistry, vol. 285, no. 10, pp. 7153-7164, 2010.
186. T. Coskun, H. A. Bina, M. A. Schneider et al., "Fibroblast growth factor 21 corrects obesity in mice, " Endocrinology, vol. 149, no. 12, pp. 6018-6027, 2008.
187. M. Petruzzelli, M. Schweiger, R. Schreiber et al., "A switch from white to brown fat increases energy expenditure in cancerassociated cachexia, " CellMetabolism, vol. 20, no. 3, pp. 433-447, 2014.
188. M. Bordicchia, D. Liu, E.-Z. Amri et al., "Cardiac natriuretic peptides act via p38MAPKto induce the brownfat thermogenic program in mouse and human adipocytes, " The Journal of Clinical Investigation, vol. 122, no. 3, pp. 1022-1036, 2012.
189. L. D. Roberts, P. Boström, J. F. O'Sullivanet al., "-Aminoisobutyric acid induces browning ofwhite fat and hepatic-oxidation and is inversely correlated with cardiometabolic risk factors, " Cell Metabolism, vol. 19, no. 1, pp. 96-108, 2014.
190. N. Jeremic, P. Chaturvedi, and S. C. Tyagi, "Browning of white fat: novel insight into factors, mechanisms, and therapeutics, " Journal of Cellular Physiology, 2016.
191. E. Subbotina, A. Sierra, Z. Zhu et al., "Musclin is an activitystimulated myokine that enhances physical endurance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 52, pp. 16042-16047, 2015.
192. F. Norheim, T. M. Langleite, M. Hjorth et al., "The effects of acute and chronic exercise on PGC-1, irisin and browning of subcutaneous adipose tissue in humans, " FEBS Journal, vol. 281, no. 3, pp. 739-749, 2014.
193. B. A. Irving, C. D. Still, and G. Argyropoulos, "Does IRISIN have a BRITE future as a therapeutic agent in humans" Current Obesity Reports, vol. 3, no. 2, pp. 235-241, 2014.
194. E. Brailoiu, E. Deliu, R. A. Sporici, and G. C. Brailoiu, "Irisin evokes bradycardia by activating cardiac-projecting neurons of nucleus ambiguus, " Physiological Reports, vol. 3, no. 6, Article ID e12419, 2015.
195. C. Xie, Y. Zhang, T. D. N. Tran et al., "Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts, " PLoS ONE, vol. 10, no. 8, Article IDe0136816, 2015.
196. M. Fernández-Galilea, P. Pérez-Matute, P. L. Prieto-Hontoria et al., "-Lipoic acid treatment increases mitochondrial biogenesis and promotes beige adipose features in subcutaneous adipocytes from overweight/obese subjects, " Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1851, no. 3, pp. 273-281, 2015.